Procedure for Stability Testing of Drugs with Complex APIs
1) Purpose
The purpose of this SOP is to define a procedure for conducting stability studies for drugs with complex active pharmaceutical ingredients (APIs) in compliance with relevant regulatory guidelines. This ensures that such drugs maintain their quality, safety, and efficacy throughout their shelf life.
2) Scope
This SOP applies to all personnel involved in the stability testing of drugs with complex APIs, including formulation development, quality control, and regulatory affairs teams.
3) Responsibilities
Formulation Development Team: Responsible for developing drug formulations containing complex APIs and selecting appropriate packaging materials.
Stability Study Team: Responsible for conducting stability studies according to approved protocols.
Regulatory Affairs Team: Responsible for ensuring compliance with regulatory requirements and submitting stability data to the authorities.
4) Procedure
4.1 Protocol Development
4.1.1 Develop a stability testing protocol that includes parameters specific
to complex APIs, such as solubility, polymorphic form, and degradation pathways.4.1.2 Define storage conditions (e.g., room temperature, accelerated) and testing intervals (e.g., 0, 3, 6, 12 months) based on regulatory guidelines.
4.2 Sample Preparation and Storage
4.2.1 Prepare samples in their final packaging for stability testing, ensuring consistency in packaging configuration.
4.2.2 Store samples under
4.3 Conducting Stability Tests
4.3.1 Perform stability tests at all required intervals, including assessments of API stability, impurity profile, and physical attributes.
4.3.2 Record all data accurately and ensure compliance with the approved protocol.
4.4 Data Analysis and Reporting
4.4.1 Analyze stability data to detect any trends, deviations, or failures that could impact product quality.
4.4.2 Prepare a comprehensive stability report for regulatory submission, including all findings and conclusions.
5) Abbreviations, if any
API: Active Pharmaceutical Ingredient
QA: Quality Assurance
6) Documents, if any
6.1 Stability testing protocols
6.2 Data sheets
6.3 Stability reports
7) Reference, if any
FDA Guidance for Industry: Stability Testing of Drugs with Complex APIs
8) SOP Version
Version 1.0

